Supporting Health Behavior Among Persons Living With HIV Using Tech, MOST, and Behavioral Economics
SCAP2
1 other identifier
interventional
80
1 country
1
Brief Summary
The present study focuses on adult persons living with HIV in the New York City and Newark, New Jersey metropolitan areas who are not highly adherent to HIV medication and who do not evidence undetectable HIV viral load (the ultimate goal of HIV treatment). Those who have not decided whether they wish to take HIV medications are invited to enroll. The study uses technology, is grounded in principles of behavioral economics, and uses the multiphase optimization strategy (MOST) to examine the acceptability, feasibility, and evidence of efficacy of three intervention components. The components are intended to increase rates of HIV viral suppression in the sample. The three components are: prizes for viral suppression (fixed compensation \[$275\] or lottery prizes \[up to $500\]), text messages and quiz questions that generate points to earn prizes (to foster engagement), and counseling sessions grounded in the motivational interviewing approach to help participants articulate goals with respect to health and viral suppression, identify and resolve barriers to HIV medication use, and build motivation for viral suppression. Participants are assessed at baseline and then 5- and 8-months later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2020
CompletedStudy Start
First participant enrolled
August 14, 2020
CompletedFirst Posted
Study publicly available on registry
August 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2022
CompletedNovember 1, 2022
July 1, 2022
1.9 years
August 14, 2020
October 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Undetectable HIV viral load
achievement of undetectable HIV viral load (\< 200 pp/mL)
5-months post-baseline
Undetectable HIV viral load
achievement of undetectable HIV viral load (\< 200 pp/mL)
8-months post-baseline
Study Arms (8)
Condition 1
EXPERIMENTALCore, fixed compensation, TMQQ, MI sessions
Condition 2
EXPERIMENTALCore, lottery prize, TMQQ, MI sessions
Condition 3
EXPERIMENTALCore, fixed compensation, MI sessions
Condition 4
EXPERIMENTALCore, lottery prize, MI sessions
Condition 5
EXPERIMENTALCore, fixed compensation, TMQQ
Condition 6
EXPERIMENTALCore, lottery prize, TMQQ
Condition 7
EXPERIMENTALCore, fixed compensation
Condition 8
EXPERIMENTALCore, lottery prize
Interventions
Three counseling sessions lasting less than 60 minutes each to identify goals, factors that promote or impede goals, and increase "readiness" for ART with high adherence
Weekly text messages with health information as well as motivational messages. Two days later a true/false quiz question is sent. Participants earn 4 points for answering correctly, 2 points for answering incorrectly, and 0 points for not answering. Participants earn $1 for each point. Messages are sent over 21 weeks.
Participants who achieve HIV viral suppression at 21 weeks will receive either fixed compensation of $275 or be entered into a lottery where they have a 3/10 chance of winning $500, and a 7/10 chance of winning $175. Those who do not achieve HIV viral suppression receive a $50 participant incentive.
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Has diagnosis of HIV infection
- Resides in the New York City or Newark, NJ metropolitan areas
- Can conduct research activities in English
- Has a phone that can send and receive text messages
- Has not participated in a conditional economic incentive program for HIV viral suppression in the past month
- Has not been enrolled in this research team's two recent studies
- Has detectable HIV viral load (\> 200 pp/mL) by lab report
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University Silver School of Social Work
New York, New York, 10003, United States
Related Publications (1)
Filippone P, Serrano S, Gwadz M, Cleland CM, Freeman R, Linnemayr S, Cluesman SR, Campos S, Rosmarin-DeStefano C, Amos B, Israel K. A virtual pilot optimization trial for African American/Black and Latino persons with non-suppressed HIV viral load grounded in motivational interviewing and behavioral economics. Front Public Health. 2023 May 10;11:1167104. doi: 10.3389/fpubh.2023.1167104. eCollection 2023.
PMID: 37234760DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marya Gwadz, PhD
New York U
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2020
First Posted
August 19, 2020
Study Start
August 14, 2020
Primary Completion
July 15, 2022
Study Completion
July 15, 2022
Last Updated
November 1, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share